Molecular epidemiological analysis ofPseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients
- 28 Downloads
A combination of esterase electrophoretic typing and analysis of the restriction fragment length polymorphism of ribosomal DNA regions (ribotyping) was used to compare 27Pseudomonas aeruginosa strains isolated before and after two-week courses of anti-pseudomonal treatment in seven cystic fibrosis patients. A total of 12 courses of therapy were studied in which ciprofloxacin, ceftazidime, azlocillin or imipenem were used alone or in combination with tobramycin. Isolates at a count of ≥ 106 cfu/ml of sputum were collected when there was evidence of therapeutic failure on the basis of persistence of isolates whether or not they were resistant to the antibiotic used for therapy. Emergence of resistance was observed in ten cases and failure to eradicate sensitive strains in five cases. Among the 27 isolates, eight zymotypes and five ribotypes were identified. With this typing approach, resistant post-therapy isolates were found to be identical to pre-therapy isolates in all cases but one. However, in one case an additional resistant strain was isolated after therapy besides that initially present. In all five cases in which susceptibility was still observed after treatment, pretherapy and post-therapy isolates were indistinguishable. Using this molecular typing approach, all the strains were typable. Thus combination of esterase typing and ribotyping should improve the analysis of therapeutic failure in cystic fibrosis patients.
KeywordsCystic Fibrosis Restriction Fragment Length Polymorphism Resistant Strain Ceftazidime Tobramycin
Unable to display preview. Download preview PDF.
- 3.Høiby N, Flensborg EW, Beck B, Friis B, Jacobsen SV, Jacobsen L:Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance ofPseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scandinavian Journal of Respiratory Disease 1977, 58: 65–79.Google Scholar
- 4.Brokopp CD, Farmer JJ: Typing methods forPseudomonas aeruginosa. In: Doggett RG (ed):Pseudomonas aeruginosa: clinical manifestations of infections and current therapy. Academic Press, New York, 1979, p. 89–133.Google Scholar
- 6.Lanyi B, Lantos J: Antigenic changes inPseudomonas aeruginosa in vivo and after lysogenization in vitro. Acta Microbiologica Hungarica 1976, 23: 337–351.Google Scholar
- 8.Ojeniyi B, Baek L, Høiby N: Polyagglutinability due to loss of O-antigenic determinants inPseudomonas aeruginosa strains isolated from cystic fibrosis patients. Acta Pathologica Microbiologica Immunologica Scandinavica B 1985, 93: 7–13.Google Scholar
- 9.Pitt TL: Epidemiological typing ofPseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 238–247.Google Scholar
- 10.Denamur E, Picard B, Goullet Ph, Bingen E, Lambert N, Elion J: Complexity ofPseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis. Epidemiology and Infection 1991, 106: 531–539.PubMedGoogle Scholar
- 11.National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard, M2-A3. NCCLS, Villanova, PA, 1984.Google Scholar
- 12.National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, M7-A. NCCLS, Villanova, PA, 1985.Google Scholar
- 13.Uriel, J: Méthode d'électrophorèse dans des gels d'acrylamide-agarose. Bulletin de la Société de Chimie Biologique 1966, 48: 969–982.Google Scholar
- 24.Giwercman B, Lambert PA, Rosdahl V, Shand GH, Høiby N: Rapid emergence of resistance inPseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed β-lactamase producing strains. Journal of Antimicrobial Chemotherapy 1990, 26: 247–259.PubMedGoogle Scholar
- 27.Neu HC: Bacterial resistance to fluoroquinolones. Reviews of Infectious Diseases 1988, 10, Supplement 1: 57–63.Google Scholar